Nemaura Medical announces exclusive license and supply deal for SugarBEAT in GCC Region
Nemaura Medical, a medical technology company focused on the development of SugarBEAT as a non-invasive, affordable and flexible…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
13 Mar 19
Nemaura Medical, a medical technology company focused on the development of SugarBEAT as a non-invasive, affordable and flexible…
08 Mar 19
Tandem Diabetes Care, an insulin delivery and diabetes technology company, announced that it is now registered as an…
07 Mar 19
Tandem Diabetes Care, a leading insulin delivery and diabetes technology company, announced that it intends to use its…
07 Mar 19
Healthagen, an Aetna business unit within CVS Health, and Welldoc, in collaboration with LifeScan, announced details of a…
06 Mar 19
Senseonics Holdings, a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose…
04 Mar 19
The first human study of a pill designed to replace injections of biologics is today being announced by…
20 Feb 19
Irish medical technology firm Medtronic has secured breakthrough device designation from the US Food and Drug Administration (FDA)…
15 Feb 19
Medality Medical has secured the US Food and Drug Administration’s (FDA) Investigational Device Exemption (IDE) approval to carry…
15 Feb 19
Tandem Diabetes Care has secured marketing approval from the US Food and Drug Administration (FDA) for its t:Slim…
14 Feb 19
GI Dynamics, a medical device company that is developing EndoBarrier for patients with type 2 diabetes and obesity,…